AU Stock MarketDetailed Quotes

TYP Tryptamine Therapeutics Ltd

Watchlist
  • 0.033
  • +0.001+3.13%
20min DelayMarket Closed Nov 1 16:00 AET
39.23MMarket Cap-362P/E (Static)

Tryptamine Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tryptamine Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Tryptamine Therapeutics Ltd Earnings Reports

  • Tryptamine Therapeutics Ltd: Annual Report to shareholders

    Sep 30 04:21 ET

  • Tryptamine Therapeutics Ltd: Preliminary Final Report Reporting Adjustments

    Sep 30 04:16 ET

  • Tryptamine Therapeutics Ltd: Appendix 4E Preliminary Final Report

    Aug 29 19:29 ET

    • Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    % Chg

    No Data